Takeda's HyQvia® receives expanded market authorization as maintenance therapy for chronic inflammatory demyelinating polyneuropathy (CIDP)
Takeda Canada Inc. (Takeda) is pleased to announce that Health Canada has expanded the marketing authorization for HyQvia® ...
Medical Dialogues2d
Novel Therapies in Management of Haemolytic Disease of the Fetus and Newborn, reveals research
Haemolytic disease of the fetus and newborn (HDFN) occurs when there is transplacental passage of maternal immunoglobulin G ...
The American Journal of Managed Care3d
Optimizing Patient Selection for CAR T, Bispecifics, Mitigates Adverse Events in High-Risk MM
For higher-risk multiple myeloma (MM), successful patient selection and monitoring strategies are vital for the management of adverse events and the disease itself.
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Purchased by Teacher Retirement System of Texas
Teacher Retirement System of Texas grew its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 25.0% during the fourth quarter, Holdings Channel reports. The firm owned 69,044 ...
The Bolton News3d
Farnworth man felt 'pins and needles' before nerve disease diagnosis
The family of a young man who has been diagnosed with a life-changing rare nerve disease have launched an appeal to help him on the road to recovery ...
Medscape6d
Intravenous Immunoglobulin IgG Response Associated with Poor Outcome in Guillain-Barré Syndrome
Due to the autoimmune etiology of this disorder, IV immunoglobulin (IVIg) or plasma exchange (PE) are the first-line treatments in addition to management of ventilatory failure. IVIg is more ...
Medscape4d
Case Report: Passive Transfer of Hepatitis B Antibodies From Intravenous Immunoglobulin
With an ever increasing number of patients being treated with IVIg for a wide array of immune ... Recent transfusion of immunoglobulin-containing products. The presence of antibodies without ...
Signaturefd LLC Cuts Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)
Signaturefd LLC lessened its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 19.5% in the 4th quarter, ...
Millionaire 'biohacker' Bryan Johnson 'made staff declare they were OK with him wearing no clothing and hearing conversations about sex and erections'
Bryan Johnson allegedly forces his Blueprint staff to abide by 'overbroad' confidentiality contracts, the New York Times ...
rarediseaseadvisor3d
Targeted RhD Immune Globulin Strategies Improve Patient Care and Resource Use
Beyond targeted prophylaxis, alternative RhD immune globulin formulations such as WinRho ... improved administration options, such as intravenous delivery. The ability to optimize dosing based on ...